secwatch.observer — SEC 8-K summary
======================================

Issuer:     IN8BIO, INC. (INAB)
CIK:        0001740279
Form:       8-K
Filed at:   2026-02-09T23:59:59+00:00
Accession:  0001193125-26-041975
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

IN8bio appoints COO Kate Rochlin as President, effective immediately
--------------------------------------------------------------------

- Kate Rochlin, current COO, assumes additional role of President effective Feb. 4, 2026.
- Dr. Rochlin will continue serving as Chief Operating Officer of IN8bio.
- Appointment made by Board on Feb. 4, 2026; no other executive changes.
- No family relationships or transactions requiring disclosure under Regulation S-K.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1740279/000119312526041975/0001193125-26-041975-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1740279/000119312526041975/d50284d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-041975

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer